Answers are grounded in this paper and cite their sources.
Objectives Clozapine-induced hypersalivation is a common adverse effect that may negatively affect treatment adherence, quality of life, and patient satisfaction. This study aimed to translate the Drooling Severity and Frequency Scale (DSFS) into Thai and evaluate its validity and reliability among patients with psychiatric disorders receiving clozapine. Methods A cross-sectional psychometric evaluation study was conducted following established translation and cultural adaptation procedures. The original English version of the DSFS was independently translated into Thai by two bilingual translators, followed by back-translation by an independent translator. Two experts evaluated semantic equivalence between the versions. The reconciled Thai version underwent content validation by six psychiatric healthcare professionals. Face validity was assessed through cognitive interviews with 10 patients receiving clozapine. The association between the severity and frequency items was assessed using inter-item correlation, while 14-day test-retest agreement was evaluated using linear weighted Cohen’s kappa for the individual items and the intraclass correlation coefficient (ICC) for the total score. Results Fifty clozapine-treated psychiatric outpatients participated in the reliability assessment (mean age 43.8 ± 13.6 years; 72% male). The mean clozapine dose was 122.8 ± 137.4 mg/day. The Thai DSFS required approximately 1–2 minutes to complete. Content validity was excellent, with item-level and scale-level content validity indices of 1.00. Cognitive interviews indicated that the instrument was generally comprehensible and acceptable to participants. The severity and frequency items were strongly correlated ( r = 0.783). Test-retest agreement was strong for the individual items, with linear weighted kappa values of 0.823 (95% CI, 0.670-0.976) for severity and 0.829 (95% CI, 0.692-0.966) for frequency, while the total-score ICC was 0.826 (95% CI, 0.712-0.898), indicating good test-retest reliability. However, reliability estimates were lower in the subgroup of participants with hypersalivation at baseline. Conclusions The Thai version of the DSFS demonstrated satisfactory content validity, comprehensibility, a strong inter-item correlation, and good test-retest reliability in the overall sample of patients receiving clozapine. These findings provide preliminary support for its potential use as a brief and practical measure of drooling severity and frequency in Thai clinical and research settings. Further evaluation of additional measurement properties and performance across the full spectrum of clozapine-induced hypersalivation severity is needed.
No takes yet. Share an insight, caveat, or question.
Seneesrisakul et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: